why choose us

First received: January 17, 2026

Clinical Trial: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: OAG - Open-Angle Glaucoma
OHT - Ocular Hypertension

Study Type: INTERVENTIONAL


Official Title: A Masked, Randomized, Prospective Study of QLS-111-FDC in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Brief Summary: Firecrest study is evaluating the intraocular pressure (IOP)-lowering effect, safety, and tolerability of Qlaris' preservative free \[PF\], fixed-dose combination \[FDC\] investigational product (IP) in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Read more